12: Venous Thromboembolism Flashcards

1
Q

Venous thromboembolism overview

A
  • Thrombi form in deep calf veins and propagate proximally
    • Those involving popliteal vein and more proximal veins (femoral, iliac) are more likely to embolize
    • Upper extremity veins in < 10% VTE
      • Catheter associated
      • More common in athletes
      • Paget-Schroetter syndrome (effort-induced)
    • Pelvic, renal veins: rare
  • 79% of patients with pulmonary embolism (PE) have concurrent lower extremity DVT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Virchow’s Triad

A
  • Theory of VTE pathogenesis:
    • Altered blood flow (stasis): hospitalization, extended travel, casting of extremity, pregnancy
    • Endothelial injury: trauma, central venous catheter, surgery
    • Hypercoagulability (inherited vs. acquired): malignancy, heart failure, nephrotic syndrome, autoimmune dz, oral contraceptives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Inherited VTE risk factors

A
  • Factor V Leiden mutation: slower inactivation of Va by Protein C
  • Prothrombin gene mutation: increased prothrombin synthesis
  • Protein S deficiency: reduced inactivation of Va
  • Protein C deficiency: reduced inactivation of Va
  • Antithrombin deficiency: reduced inactivation of IXa, XIa, Xa, thrombin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Acute DVT clinical presentation

A
  • Sx: pain, swelling, erythema in extremity
  • PEX: assymetry, warmth, edema, cords (thrombosed superficial veins); findings nonspecific and lack accuracy
  • DDx: muscle strain, cellulitis, ruptured Baker’s cyst, post-thrombotic syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Limb ischemia

A
  • 2/2 massive proximal DVT
  • Causes severely impaired venous return
    • Venous gangrene
    • Compartment syndrome
    • Aterial compromise
  • Rare, but requires immediate therapy
  • Referred to as “phlegmasia cerulea dolens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Wells Score for DVT

A

C3PO + R2D2

Cancer within 6 months
Calf swelling (3cm difference 10cm below)
Collateral superficial veins (non-varicose)
Pitting edema confined to symptomatic leg
Oedema of the entire leg
Tenderness along deep venous system
Recently bedredden for > 3 days
Recent immobilization of leg (cast, paralysis)
DVT in the past
Diagnosis other than DVT likely (2 points off)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

D-dimer assay

A
  • D-dimer: degradation product of cross-linked fibrin
  • ↑in pts with VTE (very sensitive), but not specific
  • DVT can be ruled out with low clinic suspicion (Wells score < 2) and a negative D-dimer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Diagnosis of DVT

A
  • Duplex ultrasonography
    • ​Non-invasive test of choice; portable
    • Dx made by:
      • Abnormal compressibility of vein
      • Abnormal Doppler color flow
      • Presence of echogenic band
    • Sensitivity and specificity > 95%
    • Pts w/ high clinical suspicion but negative study should have test repeated in 5-7 days or undergo more testing
      • Contrast venography
      • Impedance plethysmography
      • Magnetic resonance venography
      • CT w/ contrast
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

May-Thurner Syndrome

A

Rare condition in which compression of the common venous outflow tract of the left lower extremity may cause DVT in the iliofemoral vein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Initial therapy for DVT

A
  • Unfractionated heparin (UFH):
    • Inactivates thrombin
    • IV
    • Narrow therapeutic window
    • Reversible w/ protamine
    • Does not cross placenta
  • Low molecular weight heparin (LMWH):
    • Inactivates Xa
    • SubQ injection
    • ↓recurrent VTE and bleeding compared to UFH
    • Caution in specific populations (pregnancy, elderly, renal dz, obese)
  • Fondaparinux
    • Newer synthetic agent
    • SubQ injection
    • Inactivates Xa
    • Equally effective as LWMH for VTE
    • Similar precautions as LMWH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Transitional therapy for DVT

A
  • Warfarin
    • Inhibits vitamin K-dependent gamma-carboxylation of II, VII, IX, X
    • Highly effective at preventing recurrent VTE
    • Overlap w/ heparin for 4-5 days
    • Treat for at least 3 months
    • Interactions with genetics, diet, drugs
    • Teratogenic
  • **Rivaroxaban **(factor Xa inhibitor)
  • **Dabigatran **(direct thrombin inhibitor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Other options for DVT therapy

A
  • Catheter directed thrombolysis
    • For large clot w/ severe swelling or limb-threatening ischemia (not routine use)
    • Improves complete clos lysis and reduced post-thrombotic syndrome, increased bleeding risk
  • IVC filter
    • When anticoagulation contraindicated
    • Prevent embolism in short-term
    • Some brands removeable
    • Does not protect against VTE long-term
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

**Pulmonary Embolism **overview

A
  • Obstruction of pulmonary artery or branches with material originating from elsewhere in the body (mostly DVT, although rarely air, tumor, fat, foreign material)
  • Recurrent PE is a common cause of death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pulmonary embolism pathophysiology

A
  • Thrombi lodge in main pulmonary artery or smaller branches
  • Platelets release vasoactive and bronchoactive agents (e.g., serotonin)
  • Pulmonary infarction occurs rarely (because dual blood supply of lung)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hemodynamic compromise in acute pulmonary embolism

A
  1. Increased pulmonary vascular resistance
  2. RV strain and ↓LV preload
  3. ↓CO, RV ischemia and failure
  4. CV collapse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Gas exchange abnormalities in acute pulmonary embolism

A
  • Most commonly, pts hypoxemic w/ respiratory alkalosis
    • V/Q mismatch: pulmonary blood flow redirected toward region of low alveolar ventilation
    • Intrapulmonary shunting
  • Gas exchange normal or mildly impaired
17
Q

Clinical presentation of acute pulmonary embolism

A
  • Symptoms:
    • Dyspnea
    • Pleuritic pain
    • Leg pain/swelling
    • Cough
    • Wheezing
    • Hemoptysis
  • Signs:
    • Tachypnea
    • DVT signs
    • Tachycardia
    • Abnormal breath sounds
    • Signs of right heart failure
18
Q

Wells Score for PE

A

Don’t die, tell the team to calculate criteria. (DVT Sx, Dx alt. less likely, tachy, three days immob or thirty days surgery, thrombo Hx, cough up blood, cancer)

19
Q

Echocardiography in acute pulmonary embolism

A
  • Not specific or sufficient for Dx of pulmonary embolism
  • 30% of pt w/ acute PE have:
    • RV dysfunction
    • ↑RV size
    • Tricuspid valve regurg
    • Thrombus in RV
20
Q

Acute pulmonary embolism treatment

A
  • Stabilize patient (supplemental O2, hemodynamic support)
  • Assess probability of PE, bleeding risk
  • Obtain Dx tests
  • Treatments:
    • Anticoagulation: resolution from days to months, but prevent recurrent PE and reduce mortality
    • Thrombolysis (select patients)
    • IVC filter (if anticoag contraindicated)
    • Embolectomy by catheter or surgery
21
Q

When to consider PPx

A

For medical patients: older than 40 w/ limited mobility for ≥ 3 days, or have another thrombotic risk factor.

Administer heparin or LMW heparin; warning if recent GI bleed or thrombocytopenia.

Mechanical: intermittent pneumatic compression (for pts. with high risk of bleeding).